Dulaglutide overview
Weekly GLP-1 receptor agonist. Brand name: Trulicity. FDA-approved for type 2 diabetes mellitus.
Dulaglutide at a glance
Related pages
- Clinical research overview
- Compare GLP-1 forms
- Compounded vs brand
- NexLife (highest v4.1 score)
Key facts, checked November 20, 2026
Trulicity (dulaglutide) is a once-weekly injection. Its Trulicity label covers blood-sugar control in adults and children 10 and older with type 2 diabetes, and lowering the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes and heart disease or several risk factors. It is not approved for weight management. FDA’s November 9, 2026 safety communication requires every approved GLP-1 label, including dulaglutide’s, to add a warning about NAION, a sudden loss of vision in one eye. No telehealth program we score lists dulaglutide as a weight-loss option.